blueskyvaccines.com
About company
BlueSky Vaccines's mission is to fully exploit the potential of virotherapy against cancer. By combining tumor cell killing activities of oncolytic viruses with immunostimmulatory transgenes and antigenes, oncolytic vaccines are generated. Our platform consists of oncolytic vaccines that effectively destroy tumor cells express immunmodulatory cytokines express tumor associated antigens replicate selectively in tumor cells The unique property of this platform is the availability of antigenically different candidates, which is a pre-requisite for an effective prime/boost scenario. Moreover, BlueSky Vaccines's oncolytic vaccine was designed to induce immune responses capable to overcome the immunosuppression induced by cancers. These features have the potential to reveal substantial increases in response and overall survival rates as compared to current virotherapy and other cancer therapy approaches.
